Cargando…
Characterization of erenumab and rimegepant on calcitonin gene-related peptide induced responses in Xenopus Laevis oocytes expressing the calcitonin gene-related peptide receptor and the amylin-1 receptor
BACKGROUND: The clinical use of calcitonin gene-related peptide receptor (CGRP-R) antagonists and monoclonal antibodies against CGRP and CGRP-R has offered new treatment possibilities for migraine patients. CGRP activates both the CGRP-R and structurally related amylin 1 receptor (AMY(1)-R). The rel...
Autores principales: | Hage La Cour, Sanne, Juhler, Kiki, Kogelman, Lisette J. A., Olesen, Jes, Klærke, Dan Arne, Kristensen, David Møbjerg, Jansen-Olesen, Inger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134599/ https://www.ncbi.nlm.nih.gov/pubmed/35614383 http://dx.doi.org/10.1186/s10194-022-01425-9 |
Ejemplares similares
-
Calcitonin Gene-Related Peptide (Cgrp), Adrenomedullin (Am), Amylin, And Calcitonin (Ct) Receptors And Overlapping Biological Actions
por: Fischer, J.A., et al.
Publicado: (2001) -
Calcitonin/Amylin Receptors and Ramps
por: Sexton, Patrick M.
Publicado: (2001) -
Migraine induction with calcitonin gene-related peptide in patients from erenumab trials
por: Christensen, Casper Emil, et al.
Publicado: (2018) -
Erenumab: A novel calcitonin gene-related peptide receptor antagonist developed specifically for migraine prevention
por: Garg, Shuchita, et al.
Publicado: (2020) -
Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021)